Comparative Analysis of Outcomes Among Patients Treated With Xeljanz vs

See also
Status	Clinical Trial	Phase
Terminated	`NCT01682512` - Efficacy, Pharmacokinetics, and Safety of BI 695500 in Patients With Rheumatoid Arthritis	Phase 3
Completed	`NCT00539760` - A Phase I Rheumatoid Arthritis Study in Healthy Volunteers	Phase 1
Active, not recruiting	`NCT03312465` - Anatomical Shoulder Domelock System Study
Completed	`NCT01208181` - A Two-Part, 12-Week Study of Etoricoxib as a Treatment for Rheumatoid Arthritis (RA) (MK-0663-107)	Phase 3
Completed	`NCT03254810` - Comparison of the Safety and PK of SYN060 to Humira® in Healthy Adult Subjects	Phase 1
Completed	`NCT01711814` - A Study to Evaluate the Long-term Safety and Efficacy of ASP015K in Subjects Previously Enrolled in a Phase 2 ASP015K Rheumatoid Arthritis Study	Phase 2
Completed	`NCT03315494` - Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of SKI-O-703 in Healthy Volunteers	Phase 1
Withdrawn	`NCT03241446` - Pharmacokinetics and Dosimetry of Tc 99m Tilmanocept Following a Single Intravenous Dose Administration in Male and Female Subjects Diagnosed With Rheumatoid Arthritis (RA)	Phase 1
Completed	`NCT02748785` - MTX Discontinuation and Vaccine Response	Phase 4
Completed	`NCT02553018` - Comparison of Compliance and Evolution of Functional Capacity of Patients With Rheumatoid Arthritis Treated by Methotrexate Either by Auto-injector or by Conventional Sub-cutaneous Syringe	Phase 3
Active, not recruiting	`NCT02260778` - Treat-to-target in RA: Collaboration To Improve adOption and adhereNce	N/A
Completed	`NCT02569736` - Characterization of the Effect of Tocilizumab in Vivo and in Vitro on T Follicular Helper Cells in Rheumatoid Arthritis Patients and Consequence on B Cells Maturation
Completed	`NCT01750931` - This Study is Randomised, Single Oral Dose Bioequivalence Study of Meloxicam GSK 15 MG Tablets.	Phase 2
Not yet recruiting	`NCT01154647` - Pain Inhibition in Patients With Rheumatoid Arthritis and Central Sensitivity Syndromes	N/A
Withdrawn	`NCT01204138` - Concomitant Use of Apremilast for the Treatment of Active RA Despite TNF-Inhibition and Methotrexate- CATARA	Phase 2
Completed	`NCT00975130` - Subcutaneous Golimumab (GLM) Plus DMARDs for Rheumatoid Arthritis, Followed by Intravenous/Subcutaneous GLM Strategy (P06129 AM2)	Phase 3
Completed	`NCT00973479` - An Effectiveness and Safety Study of Intravenous Golimumab in Patients With Active Rheumatoid Arthritis Despite Treatment With Methotrexate Therapy	Phase 3
Completed	`NCT00913458` - Study Evaluating Etanercept Plus Methotrexate in Early Rheumatoid Arthritis	Phase 4
Completed	`NCT00550446` - A Phase 2 Study For Patients With A Physician's Diagnosis Of Rheumatoid Arthritis	Phase 2
Completed	`NCT00660647` - Optimized Treatment Algorithm for Patients With Early Rheumatoid Arthritis (RA)	Phase 3

NCT number	NCT03964649
Study type	Observational
Source	Pfizer
Contact
Status	Completed
Phase
Start date	January 1, 2019
Completion date	April 6, 2020

Comparative Analysis of Outcomes Among Patients Treated With Xeljanz vs Biologics

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms